Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alind Gupta

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Journal of Comparative Effectiveness Research|October 6, 2025
Estimating per-protocol effects in external comparator analyses using real-world dataAlind Gupta, Evie Merinopoulou, Stephen J Duffield, et al.
JAMA Network Open|May 25, 2022
Association Between Smoking History and Overall Survival in Patients Receiving Pembrolizumab for First-Line Treatment of Advanced Non-Small Cell Lung CancerSanjay Popat, Stephen V Liu, Nicolas Scheuer, et al.
JAMA Network Open|October 7, 2021
Assessment of Alectinib vs Ceritinib in ALK-Positive Non-Small Cell Lung Cancer in Phase 2 Trials and in Real-world DataSamantha Wilkinson, Alind Gupta, Nicolas Scheuer, et al.
Annals of Epidemiology|December 23, 2022
Head-to-head comparison of FOLFIRINOX versus gemcitabine plus nab-paclitaxel in advanced pancreatic cancer: a target trial emulation using real-world dataDevon J Boyne, Darren R Brenner, Alind Gupta, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|October 18, 2019
Probabilistic Graphical Modeling for Estimating Risk of Coronary Artery Disease: Applications of a Flexible Machine-Learning MethodAlind Gupta, Justin J Slater, Devon Boyne, et al.
Pharmaceutical Statistics|February 8, 2024
Assessing the performance of group-based trajectory modeling method to discover different patterns of medication adherenceAwa Diop, Alind Gupta, Sabrina Mueller, et al.
Cancer|November 7, 2023
Association between treatment and improvements in overall survival of patients with advanced/metastatic non-small cell lung cancer since 2011: A study in the United States, Canada, and Germany using retrospective real-world databasesFrank Griesinger, Sreeram Ramagopalan, Winson Y Cheung, et al.
JAMA Network Open|November 3, 2022
Transportability of Overall Survival Estimates From US to Canadian Patients With Advanced Non-Small Cell Lung Cancer With Implications for Regulatory and Health Technology AssessmentSreeram V Ramagopalan, Sanjay Popat, Alind Gupta, et al.
G3 (Bethesda, Md.)|July 19, 2024
A random mutagenesis screen enriched for missense mutations in bacterial effector proteinsMalene L Urbanus, Thomas M Zheng, Anna N Khusnutdinova, et al.
JCO Clinical Cancer Informatics|March 25, 2021
Risk Prediction Using Bayesian Networks: An Immunotherapy Case Study in Patients With Metastatic Renal Cell CarcinomaAlind Gupta, Paul Arora, Darren Brenner, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Journal of Comparative Effectiveness Research|October 6, 2025
Estimating per-protocol effects in external comparator analyses using real-world dataAlind Gupta, Evie Merinopoulou, Stephen J Duffield, et al.
JAMA Network Open|May 25, 2022
Association Between Smoking History and Overall Survival in Patients Receiving Pembrolizumab for First-Line Treatment of Advanced Non-Small Cell Lung CancerSanjay Popat, Stephen V Liu, Nicolas Scheuer, et al.
JAMA Network Open|October 7, 2021
Assessment of Alectinib vs Ceritinib in ALK-Positive Non-Small Cell Lung Cancer in Phase 2 Trials and in Real-world DataSamantha Wilkinson, Alind Gupta, Nicolas Scheuer, et al.
Annals of Epidemiology|December 23, 2022
Head-to-head comparison of FOLFIRINOX versus gemcitabine plus nab-paclitaxel in advanced pancreatic cancer: a target trial emulation using real-world dataDevon J Boyne, Darren R Brenner, Alind Gupta, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|October 18, 2019
Probabilistic Graphical Modeling for Estimating Risk of Coronary Artery Disease: Applications of a Flexible Machine-Learning MethodAlind Gupta, Justin J Slater, Devon Boyne, et al.
Pharmaceutical Statistics|February 8, 2024
Assessing the performance of group-based trajectory modeling method to discover different patterns of medication adherenceAwa Diop, Alind Gupta, Sabrina Mueller, et al.
Cancer|November 7, 2023
Association between treatment and improvements in overall survival of patients with advanced/metastatic non-small cell lung cancer since 2011: A study in the United States, Canada, and Germany using retrospective real-world databasesFrank Griesinger, Sreeram Ramagopalan, Winson Y Cheung, et al.
JAMA Network Open|November 3, 2022
Transportability of Overall Survival Estimates From US to Canadian Patients With Advanced Non-Small Cell Lung Cancer With Implications for Regulatory and Health Technology AssessmentSreeram V Ramagopalan, Sanjay Popat, Alind Gupta, et al.
G3 (Bethesda, Md.)|July 19, 2024
A random mutagenesis screen enriched for missense mutations in bacterial effector proteinsMalene L Urbanus, Thomas M Zheng, Anna N Khusnutdinova, et al.
JCO Clinical Cancer Informatics|March 25, 2021
Risk Prediction Using Bayesian Networks: An Immunotherapy Case Study in Patients With Metastatic Renal Cell CarcinomaAlind Gupta, Paul Arora, Darren Brenner, et al.
Pageof 3